v3.26.1
Stock Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense Recognized in the Period
The following table presents the share-based compensation expense by award type recognized within the following line items in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and Condensed Consolidated Balance Sheet in the periods presented:
Three Months Ended March 31,
20262025
Restricted stock units$19,227 $23,536 
Stock options896 2,274 
Performance restricted stock units
(296)(81)
Employee Stock Purchase Plan
190 186 
Share-based compensation recorded within Compensation and benefits
20,017 25,915 
Property and equipment (capitalized internal-use software)
2,606 2,522 
Total share-based compensation expense
$22,623 $28,437 
Schedule of Stock Options Activity Under the Plans
A summary of the Company's restricted stock units (RSUs) and performance-based restricted stock units (PSUs) activity under the Plans was as follows:
Number of Units
Weighted- average grant date fair value per share
Balance as of December 31, 2025
29,086 $4.88 
Granted
20,944 $3.98 
Vested
(5,106)$4.94 
Forfeited
(3,979)$4.47 
Balance as of March 31, 2026
40,945 $4.45 
A summary of the Company's stock option activity under the Plans is as follows:
Number of Options
Weighted- Average Exercise Price per Share
Weighted - Average remaining Contractual Life (Years)
Aggregate Intrinsic Value (1)
Balance as of December 31, 2025
8,197 $6.86 5.73$7,321 
Granted
— — 
Exercised
(33)1.52 
Forfeited
— — 
Balance as of March 31, 2026
8,164 $6.88 5.48$4,989 
Exercisable as of March 31, 2026 (2)
7,751 $6.96 5.40$4,987 
Vested as of March 31, 2026
7,751 $6.96 5.40$4,987 
(1) Intrinsic value is calculated based on the difference between the exercise price of in-the-money-stock options and the fair value of the common stock as of the respective balance sheet dates.
(2) The 2011 Plan allows for early exercise of stock options. Accordingly, options granted under this plan are included as exercisable stock options regardless of vesting status.